Surgeons at the National Hospital for Neurology and Neurosurgery in London successfully removed a pituitary gland tumour using a novel AI system that analyzed live camera footage to assist in identifying vital nerves and blood vessels, marking a global first in AI-assisted neurosurgery.
- AI analyzed live endoscopic footage to aid surgeons in real-time.
- Patient experienced rapid vision recovery post-operation.
- Tech learned surgical insights from hundreds of prior videos.
What happened
In May, surgeons at the National Hospital for Neurology and Neurosurgery, part of University College London Hospitals, conducted the world’s first successful AI-assisted brain tumour removal. The patient, Rhys Hibbert, had an 11mm pituitary tumour causing hormone imbalance and vision problems. The operation involved an endoscope inserted through the nose, providing live camera images for AI analysis.
The AI system processed the footage in real time, helping the surgical team distinguish nerves, blood vessels, and important tissue near the tumour. This aided navigation around sensitive structures while keeping the surgical team fully in control. Details about the patient’s swift recovery and the operation’s success were shared following the patient's recuperation.
Why it matters
This milestone marks a significant advancement in integrating AI with complex neurosurgical procedures, where precision is critical. By leveraging AI trained on hundreds of prior surgeries, the system brought a depth of experience that would normally take human surgeons years to accumulate, enhancing the accuracy of anatomical recognition and potentially reducing surgical risks.
The operation demonstrates AI’s growing capability not only to support surgeons in real time but also to improve patient outcomes, as evidenced by rapid restoration of the patient’s vision. Funded by the National Institute for Health and Care Research, the success underscores the role of AI in the future of medical innovation and surgical assistance.
What to watch next
Additionally, research will continue to refine AI learning from increasing surgical data, potentially expanding applications beyond pituitary tumours to other complex neurosurgical conditions and rare cancers. Monitoring these advancements will be key for healthcare providers, regulators, and technology developers aiming to integrate AI into clinical practice.